Elston George
Insider CIK 1429932 · EYPT Chief Financial Officer · CLDX Director · CBRX Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| EYPT EyePoint, Inc. | G Gift | 2026-08-20 | 2026-08-24 | 64,953 | — | $0 | 64,953 | SEC↗ |
| EYPT EyePoint, Inc. | G Gift | 2026-08-20 | 2026-08-24 | 64,953 | — | $0 | 32,517 | SEC↗ |
| EYPT EyePoint, Inc. | J Other | 2026-08-20 | 2026-08-24 | 5,000 | — | $0 | 96,691 | SEC↗ |
| EYPT EyePoint, Inc. | J Other | 2026-08-20 | 2026-08-24 | 5,000 | — | $0 | 25,000 | SEC↗ |
| EYPT EyePoint, Inc. | G Gift | 2026-08-20 | 2026-08-24 | 64,953 | — | $0 | 64,953 | SEC↗ |
| EYPT EyePoint, Inc. | G Gift | 2026-08-20 | 2026-08-24 | 64,953 | — | $0 | 32,517 | SEC↗ |
| EYPT EyePoint, Inc. | J Other | 2026-08-20 | 2026-08-24 | 5,000 | — | $0 | 96,691 | SEC↗ |
| EYPT EyePoint, Inc. | J Other | 2026-08-20 | 2026-08-24 | 5,000 | — | $0 | 25,000 | SEC↗ |
| EYPT EyePoint, Inc. | M Exercise deriv | 2026-05-25 | 2026-05-27 | 7,500 | — | $0 | 0 | SEC↗ |
| EYPT EyePoint, Inc. | F Tax w/h | 2026-05-25 | 2026-05-27 | 3,627 | $12.93 | $46.9K | 91,691 | SEC↗ |
| EYPT EyePoint, Inc. | M Exercise | 2026-05-25 | 2026-05-27 | 7,500 | — | $0 | 95,318 | SEC↗ |
| EYPT EyePoint, Inc. | G Gift | 2026-03-02 | 2026-03-06 | 5,000 | — | $0 | 87,818 | SEC↗ |
| EYPT EyePoint, Inc. | G Gift | 2026-03-02 | 2026-03-06 | 5,000 | — | $0 | 30,000 | SEC↗ |
| EYPT EyePoint, Inc. | M Exercise deriv | 2026-01-06 | 2026-01-07 | 15,285 | — | $0 | 0 | SEC↗ |
| EYPT EyePoint, Inc. | M Exercise | 2026-01-06 | 2026-01-07 | 15,285 | — | $0 | 96,339 | SEC↗ |
| EYPT EyePoint, Inc. | F Tax w/h | 2026-01-06 | 2026-01-07 | 4,487 | $16.86 | $75.7K | 91,852 | SEC↗ |
| EYPT EyePoint, Inc. | M Exercise deriv | 2026-01-05 | 2026-01-06 | 15,000 | — | $0 | 15,000 | SEC↗ |
| EYPT EyePoint, Inc. | M Exercise | 2026-01-05 | 2026-01-06 | 15,000 | — | $0 | 85,457 | SEC↗ |
| EYPT EyePoint, Inc. | F Tax w/h | 2026-01-05 | 2026-01-06 | 4,403 | $17.43 | $76.7K | 81,054 | SEC↗ |
| EYPT EyePoint, Inc. | M Exercise deriv | 2026-01-03 | 2026-01-06 | 19,667 | — | $0 | 39,333 | SEC↗ |
| EYPT EyePoint, Inc. | M Exercise | 2026-01-03 | 2026-01-06 | 19,667 | — | $0 | 76,781 | SEC↗ |
| EYPT EyePoint, Inc. | F Tax w/h | 2026-01-03 | 2026-01-06 | 6,324 | $17.48 | $110.5K | 70,457 | SEC↗ |
| EYPT EyePoint, Inc. | A Award deriv | 2026-01-02 | 2026-01-06 | 126,000 | — | $0 | 126,000 | SEC↗ |
| EYPT EyePoint, Inc. | A Award deriv | 2026-01-02 | 2026-01-06 | 63,000 | — | $0 | 63,000 | SEC↗ |
| EYPT EyePoint, Inc. | G Gift | 2025-12-19 | 2025-12-23 | 5,000 | — | $0 | 25,000 | SEC↗ |
| EYPT EyePoint, Inc. | G Gift | 2025-12-19 | 2025-12-23 | 5,000 | — | $0 | 57,114 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | G Gift | 2025-09-19 | 2025-09-22 | 20,000 | — | $0 | 62,114 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | G Gift | 2025-09-19 | 2025-09-22 | 20,000 | — | $0 | 20,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2025-05-25 | 2025-05-27 | 7,500 | — | $0 | 7,500 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | F Tax w/h | 2025-05-25 | 2025-05-27 | 2,202 | $5.68 | $12.5K | 80,848 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2025-05-25 | 2025-05-27 | 7,500 | — | $0 | 83,050 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2025-02-09 | 2025-02-11 | 5,834 | — | $0 | 0 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2025-02-09 | 2025-02-11 | 5,834 | — | $0 | 75,550 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2025-01-06 | 2025-01-07 | 15,285 | — | $0 | 14,715 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | F Tax w/h | 2025-01-06 | 2025-01-07 | 4,808 | $8.68 | $41.7K | 68,566 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2025-01-06 | 2025-01-07 | 15,285 | — | $0 | 73,374 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2025-01-05 | 2025-01-07 | 15,000 | — | $0 | 30,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2025-01-05 | 2025-01-07 | 15,000 | — | $0 | 63,356 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | F Tax w/h | 2025-01-05 | 2025-01-07 | 5,267 | $8.26 | $43.5K | 58,089 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2025-01-03 | 2025-01-07 | 59,000 | — | $0 | 74,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2025-01-03 | 2025-01-07 | 117,000 | — | $0 | 117,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2024-05-25 | 2024-05-28 | 7,500 | — | $0 | 15,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2024-05-25 | 2024-05-28 | 7,500 | — | $0 | 51,107 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | F Tax w/h | 2024-05-25 | 2024-05-28 | 3,627 | $11.16 | $40.5K | 47,480 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2024-02-09 | 2024-02-13 | 5,833 | — | $0 | 5,834 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2024-02-09 | 2024-02-13 | 4,967 | — | $0 | 0 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2024-02-09 | 2024-02-13 | 4,967 | — | $0 | 40,966 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2024-02-09 | 2024-02-13 | 5,833 | — | $0 | 46,799 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | F Tax w/h | 2024-02-09 | 2024-02-13 | 1,734 | $28.80 | $49.9K | 45,065 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | F Tax w/h | 2024-02-09 | 2024-02-13 | 1,458 | $28.80 | $42.0K | 43,607 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2024-01-06 | 2024-01-09 | 15,285 | — | $0 | 30,570 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | F Tax w/h | 2024-01-06 | 2024-01-09 | 4,911 | $20.40 | $100.2K | 35,308 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2024-01-06 | 2024-01-09 | 15,285 | — | $0 | 40,219 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2024-01-05 | 2024-01-09 | 90,000 | — | $0 | 90,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2024-01-05 | 2024-01-09 | 45,000 | — | $0 | 45,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2023-10-16 | 2023-10-17 | 30,000 | — | $0 | 30,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2023-06-20 | 2023-06-22 | 45,855 | — | $0 | 45,855 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2023-05-25 | 2023-05-30 | 22,500 | — | $0 | 22,500 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2023-05-25 | 2023-05-30 | 45,000 | — | $0 | 45,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2023-02-09 | 2023-02-13 | 4,967 | — | $0 | 4,967 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2023-02-09 | 2023-02-13 | 5,833 | — | $0 | 11,667 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2023-02-09 | 2023-02-13 | 5,833 | — | $0 | 18,149 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2023-02-09 | 2023-02-13 | 4,967 | — | $0 | 23,116 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2023-01-06 | 2023-01-10 | 91,655 | — | $0 | 91,655 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2022-02-09 | 2022-02-11 | 17,500 | — | $0 | 17,500 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2022-02-09 | 2022-02-11 | 70,000 | — | $0 | 70,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2022-02-09 | 2022-02-11 | 4,966 | — | $0 | 9,934 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2022-02-09 | 2022-02-11 | 4,966 | — | $0 | 11,323 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | F Tax w/h | 2022-02-09 | 2022-02-11 | 1,721 | $10.13 | $17.4K | 9,602 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2021-06-22 | 2021-06-23 | 14,900 | — | $0 | 14,900 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2021-06-22 | 2021-06-23 | 60,300 | — | $0 | 60,300 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | P Buy | 2020-09-04 | 2020-09-09 | 10,000 | $0.48 | $4.8K | 40,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | P Buy | 2020-08-24 | 2020-08-26 | 10,000 | $0.61 | $6.1K | 30,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | P Buy | 2020-03-12 | 2020-03-13 | 10,000 | $0.96 | $9.6K | 20,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2020-02-28 | 2020-03-03 | 110,371 | — | $0 | 110,371 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | P Buy | 2019-11-15 | 2019-11-18 | 10,000 | $1.43 | $14.3K | 10,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2019-11-14 | 2019-11-18 | 745,000 | — | $0 | 745,000 | SEC↗ |
| JNP JUNIPER PHARMACEUTICALS IN | P Buy | 2016-08-31 | 2016-08-31 | 1,000 | $5.50 | $5.5K | 1,000 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2016-06-08 | 2016-06-09 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award | 2016-06-08 | 2016-06-09 | 10,000 | — | $0 | 28,500 | SEC↗ |
| JNP JUNIPER PHARMACEUTICALS IN | A Award deriv | 2016-02-19 | 2016-07-06 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2015-06-10 | 2015-06-11 | 10,300 | — | $0 | 10,300 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award | 2015-06-10 | 2015-06-11 | 6,500 | — | $0 | 18,500 | SEC↗ |
| CBRX COLUMBIA LABORATORIES INC | A Award deriv | 2014-10-01 | 2014-10-03 | 75,000 | — | $0 | 75,000 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2014-06-04 | 2014-06-05 | 2,000 | — | $0 | 2,000 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award | 2014-06-04 | 2014-06-05 | 2,000 | — | $0 | 12,000 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award deriv | 2013-06-19 | 2013-06-20 | 2,000 | — | $0 | 2,000 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award | 2013-06-19 | 2013-06-20 | 2,000 | — | $0 | 10,000 | SEC↗ |
| CLDX Celldex Therapeutics, Inc. | A Award | 2012-06-20 | 2012-06-21 | 2,000 | — | $0 | 8,000 | SEC↗ |